Patient info Open main menu

Water for Injections – Summary of Product Characteristics (SmPC) for healthcare professionals

Last updated: · Text from the MHRA, as of · About this document

Contains active substance:

Summary of Product Characteristics (SmPC) - Water for Injections

1 NAME OF THE MEDICINAL PRODUCT

Water for Injections

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

1 vial contains 2, 2.5, 3, 4, 5, 5.6, 10, 15, 20, 40 or 50 ml Water for Injections

3. PHARMACEUTICAL FORM

Solution for injection/infusion

4.1 Therapeutic indications

For use as a solvent for reconstitution of suitable medicinal products

4.2 Posology and method of administration

Posology

Not applicable

Method of administration

Not applicable

4.3 Contraindications

None.

4.4 Special warnings and precautions for use

None

4.5 Interaction with other medicinal products and other forms of interaction

None

4.6 Fertility, pregnancy and lactation

None

4.7 Effects on ability to drive and use machines

None.

4.8 Undesirable effects

None.

4.9 Overdose

None.

5 PHARMACOLOGICAL PROPERTIES

5.1 Pharmacodynamic properties

Pharmacotherapeutic group: Solvent and diluting agent

Pharmacodynamics: Not applicable

5.2 Pharmacokinetic properties

Not applicable.

5.3 Preclinical safety data

Not applicable.

6 PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Not applicable.

6.2 Incompatibilities

None.

6.3 Shelf life

2.5, 3, 4, 5, 5.6, 10, 15, 20, 40, 50 ml: 60 months 2 ml: 30 months

6.4 Special precautions for storage

Do not store above 30°C.

2ml: Do not store above 25°C.

Do not freeze.

6.5 Nature and contents of container

Pack sizes Container details

2 ml, 2.5 ml, 3 ml, 4 ml, 5 ml

5.6 ml, 10 ml

15 ml

20 ml

40 ml, 50 ml

In 6 ml injection vial clear glass type I (Ph. Eur.) with chlorobutyl or bromobutyl rubber infusion stopper and cap

In 10 ml injection vial clear glass type I (Ph. Eur.) with chlorobutyl or bromobutyl rubber infusion stopper and cap

In 15 ml injection vial clear glass type I (Ph. Eur.) with chlorobutyl or bromobutyl rubber infusion stopper and cap

In 25 ml injection vial clear glass type I (Ph. Eur.) with chlorobutyl or bromobutyl rubber infusion stopper and cap

In 50 ml injection vial clear glass type I (Ph. Eur.) with chlorobutyl or bromobutyl rubber infusion stopper and cap

6.6 Special precautions for disposal and other handling

  • Do not use after the expiry date given on the carton and vial label.
  • Do not use visibly cloudy solutions or solutions still containing flakes or particles.
  • Reconstitution and withdrawal must be carried out under aseptic conditions.
  • Any unused solution should be disposed of in accordance with local requirements.

7 MARKETING AUTHORISATION HOLDER

CSL Behring GmbH

Emil-von-Behring-Strasse 76

35041 Marburg

Germany

8 MARKETING AUTHORISATION NUMBER

PL 15036/0015

9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE

AUTHORISATION

31st December1997

10 DATE OF REVISION OF THE TEXT

09/07/2023

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 15036/0015

Last revision stated in the text: 9 July 2023 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Water for Injections

Active substance Water
Excipients Not applicable.
Shelf life 2.5, 3, 4, 5, 5.6, 10, 15, 20, 40, 50 ml: 60 months 2 ml: 30 months
Storage Do not store above 30°C.
2ml: Do not store above 25°C.
Do not freeze.
Drug group (ATC) Solvent and diluting agent
Marketing authorisation PL 15036/0015
Marketing authorisation holder CSL Behring GmbH

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.